|

PRTH-101 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Incendia Therapeutics1

Indications

  • Advanced or Metastatic Solid Tumors1
  • NSCLC1
  • Lung Cancer1
  • Non Small Cell Lung Cancer1
  • Cancer1

Scottsdale, Arizona1 trial

A First-in-human Study of PRTH-101 Monotherapy +/- Pembrolizumab in Subjects With Advanced Malignancies

Honor Health Research Institute

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.